| __timestamp | Amphastar Pharmaceuticals, Inc. | Rhythm Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 40373000 | 1213000 |
| Thursday, January 1, 2015 | 46974000 | 3425000 |
| Friday, January 1, 2016 | 47298000 | 6311000 |
| Sunday, January 1, 2017 | 50918000 | 9518000 |
| Monday, January 1, 2018 | 58044000 | 28080000 |
| Tuesday, January 1, 2019 | 63109000 | 36550000 |
| Wednesday, January 1, 2020 | 65157000 | 46125000 |
| Friday, January 1, 2021 | 68920000 | 68486000 |
| Saturday, January 1, 2022 | 66592000 | 92032000 |
| Sunday, January 1, 2023 | 80393000 | 117532000 |
In pursuit of knowledge
In the competitive world of pharmaceuticals, managing Selling, General, and Administrative (SG&A) expenses is crucial for profitability. Amphastar Pharmaceuticals, Inc. and Rhythm Pharmaceuticals, Inc. have shown contrasting trends in their SG&A expenses from 2014 to 2023. Amphastar has maintained a steady increase, with expenses growing by approximately 99% over the decade. In contrast, Rhythm Pharmaceuticals started with minimal expenses, but by 2023, their SG&A costs surged to nearly 97% of Amphastar's, reflecting a strategic shift or expansion. This data highlights the different growth trajectories and operational strategies of these companies. While Amphastar's consistent growth suggests stable management, Rhythm's rapid increase could indicate aggressive market positioning. Understanding these trends provides valuable insights into how each company navigates the financial landscape of the pharmaceutical industry.
Gilead Sciences, Inc. vs Rhythm Pharmaceuticals, Inc.: SG&A Expense Trends
Selling, General, and Administrative Costs: argenx SE vs Amphastar Pharmaceuticals, Inc.
Biogen Inc. and Rhythm Pharmaceuticals, Inc.: SG&A Spending Patterns Compared
Operational Costs Compared: SG&A Analysis of Biogen Inc. and Amphastar Pharmaceuticals, Inc.
Breaking Down SG&A Expenses: BeiGene, Ltd. vs Amphastar Pharmaceuticals, Inc.
Breaking Down SG&A Expenses: United Therapeutics Corporation vs Rhythm Pharmaceuticals, Inc.
Comparing SG&A Expenses: Cytokinetics, Incorporated vs Rhythm Pharmaceuticals, Inc. Trends and Insights
Cost Management Insights: SG&A Expenses for ADMA Biologics, Inc. and Rhythm Pharmaceuticals, Inc.
Operational Costs Compared: SG&A Analysis of Rhythm Pharmaceuticals, Inc. and Iovance Biotherapeutics, Inc.
Rhythm Pharmaceuticals, Inc. and Viridian Therapeutics, Inc.: SG&A Spending Patterns Compared
SG&A Efficiency Analysis: Comparing Bausch Health Companies Inc. and Amphastar Pharmaceuticals, Inc.
SG&A Efficiency Analysis: Comparing Amphastar Pharmaceuticals, Inc. and Travere Therapeutics, Inc.